Consumption of Chlorhexidine and Mupirocin Across the Health System of the US Department of Defense (DOD) and the Incidence of the qacA/B and mupA Genes in the DOD Facilities of the National Capital Region

Clin Infect Dis. 2017 Jun 15;64(12):1801-1802. doi: 10.1093/cid/cix276.

Authors

Mackenzie Morgan¹, Patrick McGann², Sarah Gierhart³, Uzo Chukwuma³, Douglas Richesson², Mary Hinkle², Emil Lesho⁴

Affiliations

¹ Infectious Diseases Service, Walter Reed National Military Medical Center, Bethesda, and.
² Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland.
³ EpiData Center Department, Naval and Marine Corps Public Health Center, Portsmouth, Virginia; and.
⁴ Uniformed Services University of Health Sciences, Bethesda, Maryland.

No abstract available

Publication types

Letter
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Anti-Infective Agents, Local / administration & dosage*
Child
Child, Preschool
Chlorhexidine / administration & dosage*
Drug Resistance, Bacterial*
Drug Utilization*
Female
Genes, Bacterial
Hospitals, Veterans
Humans
Incidence
Infant
Infant, Newborn
Male
Methicillin-Resistant Staphylococcus aureus / drug effects
Methicillin-Resistant Staphylococcus aureus / genetics*
Middle Aged
Multiplex Polymerase Chain Reaction
Mupirocin / administration & dosage*
Staphylococcal Infections / epidemiology
Staphylococcal Infections / microbiology*
United States / epidemiology
Young Adult

Substances

Anti-Infective Agents, Local
Mupirocin
Chlorhexidine